Uğur Şahin is a Turkish-German physician, oncologist and entrepreneur of Turkish origin. He has been Professor of Experimental Oncology at the III Medical Clinic of the University of Mainz since 2006. As of 2020, Forbes estimated his net worth at USD 5 billion USD.
About Uğur Şahin in brief
Uğur Şahin is a Turkish-German physician, oncologist and entrepreneur of Turkish origin. He has been Professor of Experimental Oncology at the III Medical Clinic of the University of Mainz since 2006. He is chairman of the board and CEO of BioNTech SE since 2008, a company that he co-founded with his with wife, Özlem Türeci. As of 2020, Forbes estimated his net worth at USD 5 billion USD. He and his spouse are among the hundred wealthiest people in Germany. His main fields of research are cancer research and immunology. He sees himself as an immune engineer who tries to use the body’s antiviral mechanisms to treat, for example, cancer when the immune system is otherwise unable to fight it. His aim is to develop a cancer vaccine based on ribonucleic acid, a messenger substance with genetic information that triggers a corresponding reaction of the immune System.
These RNA vaccines do not cause a permanent genetic change in the genetic material of the cells. However, they are, in simple terms, dissolved again after single-use to form a protein. He was awarded the German Cancer Prize 2019 for his work in the field of cancer immunology in 2017. In 2011, he founded UCTor Diseases Mainz, an association of all oncologically active institutions that focus on clinical or oncological research. In 2017, he was involved in establishing the new Helmholtz Institute HI-TRON, which is a cooperation between the German Research Center for Tumor Diseases and TRON Mainz.
You want to know more about Uğur Şahin?
This page is based on the article Uğur Şahin published in Wikipedia (as of Dec. 07, 2020) and was automatically summarized using artificial intelligence.
